Literature DB >> 1317345

Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study.

K Ueda1, T Terada, Y Nakanuma, O Matsui.   

Abstract

Vascular supply of adenomatous hyperplasia (AH) of the liver, a preneoplastic or early neoplastic lesion of hepatocellular carcinoma (HCC), and that of HCC were morphometrically examined. Seventy-three nodules of AH were divided into 43 ordinary and 30 atypical AHs. The latter showed a variety of hepatocellular atypias that were, however, insufficient to make a diagnosis of HCC, while the former lacked such atypias. Arteries were slightly more numerous and portal veins were slightly less frequent in both ordinary and atypical AHs compared with the surrounding liver. In ordinary AHs, cumulative areas of arterial lumen and portovenous lumen were almost equal to or less than those in the surrounding liver in two thirds of our cases. The cumulative area of arterial lumen was equal to, and that of portovenous lumen was less than, the cumulative area in the surrounding liver in the remaining one third of our cases. In a majority of atypical AHs, the cumulative area of arterial lumen was equal to, and that of portovenous lumen was less than, the cumulative area in the surrounding liver. In most HCC nodules, the number and cumulative luminal area of arteries were much more, and those of portal veins were much less, than the number and cumulative area in the surrounding liver. The relative number and cumulative luminal area of abnormal arteries compared with all arteries showed a stepwise increase in the following order: ordinary AH (20.7% and 17.5%), atypical AH (46.8% and 52.5%), and HCC (93.6% and 92.0%). These data suggest that ordinary AH, atypical AH, and HCC are different in vascular supply, and that these differences may reflect sequential changes in the hemodynamic state during hepatocarcinogenesis.

Entities:  

Mesh:

Year:  1992        PMID: 1317345     DOI: 10.1016/0046-8177(92)90316-u

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

Review 1.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

2.  Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling.

Authors:  Tong San Koh; Choon Hua Thng; Septian Hartono; Puor Sherng Lee; Su Pin Choo; Donald Y H Poon; Han Chong Toh; Sotirios Bisdas
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

3.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

4.  Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.

Authors:  F Loria; G Loria; S Basile; G Crea; D Randazzo; L Frosina
Journal:  Updates Surg       Date:  2012-10-07

5.  Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.

Authors:  Katjana Daskalow; Nadine Rohwer; Esther Raskopf; Evelyne Dupuy; Anja Kühl; Christoph Loddenkemper; Bertram Wiedenmann; Volker Schmitz; Thorsten Cramer
Journal:  J Mol Med (Berl)       Date:  2010-04-12       Impact factor: 4.599

6.  Detection of hepatocellular carcinoma capsule by contrast-enhanced ultrasound using Levovist: correlations with pathological findings.

Authors:  Pabitra K Bhattacharjee; Akiko Saito; Michiyo Chiba; Hideo Katsuragawa; Ken Takasaki
Journal:  J Med Ultrason (2001)       Date:  2005-12       Impact factor: 1.314

7.  Parametric imaging using contrast-enhanced ultrasound with Sonazoid for hepatocellular carcinoma.

Authors:  Manabu Watanabe; Kazue Shiozawa; Masayoshi Takahashi; Noritaka Wakui; Yuichiro Otsuka; Hironori Kaneko; Kayoko Tanikawa; Kazutoshi Shibuya; Naohisa Kamiyama; Yasukiyo Sumino
Journal:  J Med Ultrason (2001)       Date:  2010-01-05       Impact factor: 1.314

8.  Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.

Authors:  Rieko Shinmura; Osamu Matsui; Masumi Kadoya; Satoshi Kobayashi; Noboru Terayama; Junichiro Sanada; Hiroshi Demachi; Toshifumi Gabata
Journal:  Eur Radiol       Date:  2008-04-02       Impact factor: 5.315

9.  Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.

Authors:  Li-Da Chen; Hui-Xiong Xu; Xiao-Yan Xie; Xiao-Hua Xie; Zuo-Feng Xu; Guang-Jian Liu; Zhu Wang; Man-Xia Lin; Ming-De Lu
Journal:  Eur Radiol       Date:  2009-09-04       Impact factor: 5.315

10.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.